Current Affairs First Circuit Decisions Securities Class Actions
November 30, 2016 / February 26, 2019 by Mark Rosen
On November 28, 2016, the First Circuit upheld the dismissal of all but one of the class action securities fraud claims against Cambridge, MA drug company, ARIAD Pharmaceuticals, Inc., reaffirming the exacting pleading standards that enable defendants to put an early end to reflexive stock-drop lawsuits. In doing so, the First Circuit also adopted strict […]
Read more »
